These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 29628384

  • 21. Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia.
    Kim MW, Lim JY, Oh SH.
    Scand J Clin Lab Invest; 2017 Nov; 77(7):486-492. PubMed ID: 28678546
    [Abstract] [Full Text] [Related]

  • 22. Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.
    Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agustí C, Angrill J, García E, Mensa J, Niederman MS, Torres A.
    Chest; 2007 Aug; 132(2):515-22. PubMed ID: 17505026
    [Abstract] [Full Text] [Related]

  • 23. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, Esteban C, Bereciartua E, Unanue U, Uranga A.
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M, Gutiérrez F, Shum C, Padilla S, Navarro JC, Flores E, Hernández I.
    Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
    [Abstract] [Full Text] [Related]

  • 26. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
    Christ-Crain M, Stolz D, Jutla S, Couppis O, Müller C, Bingisser R, Schuetz P, Tamm M, Edwards R, Müller B, Grossman AB.
    Am J Respir Crit Care Med; 2007 Nov 01; 176(9):913-20. PubMed ID: 17702966
    [Abstract] [Full Text] [Related]

  • 27. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.
    Bello S, Lasierra AB, Mincholé E, Fandos S, Ruiz MA, Vera E, de Pablo F, Ferrer M, Menendez R, Torres A.
    Eur Respir J; 2012 May 01; 39(5):1144-55. PubMed ID: 22075489
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Risk Factors for Death from Psychiatric Hospital-acquired Pneumonia.
    Haga T, Ito K, Sakashita K, Iguchi M, Ono M, Tatsumi K.
    Intern Med; 2018 Sep 01; 57(17):2473-2478. PubMed ID: 29607949
    [Abstract] [Full Text] [Related]

  • 31. Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.
    Heppner HJ, Bertsch T, Alber B, Esslinger AS, Dragonas C, Bauer JM, Sieber CC.
    Gerontology; 2010 Sep 01; 56(4):385-9. PubMed ID: 19940454
    [Abstract] [Full Text] [Related]

  • 32. Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.
    Salluh JIF, Bozza FA, Soares M, Verdeal JCR, Castro-Faria-Neto HC, Lapa E Silva JR, Bozza PT.
    Chest; 2008 Nov 01; 134(5):947-954. PubMed ID: 18753464
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia.
    Viasus D, Garcia-Vidal C, Simonetti A, Manresa F, Dorca J, Gudiol F, Carratalà J.
    J Infect; 2013 May 01; 66(5):415-23. PubMed ID: 23286966
    [Abstract] [Full Text] [Related]

  • 35. Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens.
    Wang PH, Wang HC, Cheng SL, Chang HT, Laio CH.
    J Formos Med Assoc; 2016 May 01; 115(5):356-63. PubMed ID: 25944735
    [Abstract] [Full Text] [Related]

  • 36. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Werner Z, Mueller B, Schuetz P, ProHOSP Study Group.
    Clin Chem Lab Med; 2015 Mar 01; 53(4):559-66. PubMed ID: 25014522
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M.
    BMC Infect Dis; 2007 Mar 02; 7():10. PubMed ID: 17335562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.